CoChat

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life

Open access

Abstract

A diverse set of biological processes have been implicated in the pathophysiology of Alzheimer’s disease (AD) and related dementias. However, there is limited understanding of the peripheral biological mechanisms relevant in the earliest phases of the disease. Here, we used a large-scale proteomics platform to examine the association of 4877 plasma proteins with 25-year dementia risk in 10,981 middle-aged adults. We found 32 dementia-associated plasma proteins that were involved in proteostasis, immunity, synaptic function, and extracellular matrix organization. We then replicated the association between 15 of these proteins and clinically relevant neurocognitive outcomes in two independent cohorts. We demonstrated that 12 of these 32 dementia-associated proteins were associated with cerebrospinal fluid (CSF) biomarkers of AD , neurodegeneration, or neuroinflammation. We found that eight of these candidate protein markers were abnormally expressed in human postmortem brain tissue from patients with AD, although some of the proteins that were most strongly associated with dementia risk, such as GDF15, were not detected in these brain tissue samples. Using network analyses, we found a protein signature for dementia risk that was characterized by dysregulation of specific immune and proteostasis/autophagy pathways in adults in midlife ~20 years before dementia onset, as well as abnormal coagulation and complement signaling ~10 years before dementia onset. Bidirectional two-sample Mendelian randomization genetically validated nine of our candidate proteins as markers of AD in midlife and inferred causality of SERPINA3 in AD pathogenesis. Last, we prioritized a set of candidate markers for AD and dementia risk prediction in midlife.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.adf5681

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 103 references

Research works printed but not linked: 1

  1. 10.1038/s41588-020-0682-6 · doi:10.1038/s41588-020-0682-6 · Paper page

Cited by

See all 148

Metadata

Authors
Walker, K. A., Chen, J., Shi, L., Yang, Y., Fornage, M., Zhou, L., Schlosser, P., Surapaneni, A., Grams, M. E., Duggan, M. R., Peng, Z., Gomez, G. T., Tin, A., Hoogeveen, R. C., Sullivan, K. J., Ganz, P., Lindbohm, J. V., Kivimaki, M., Nevado-Holgado, A. J., Buckley, N., Gottesman, R. F., Mosley, T. H., Boerwinkle, E., Ballantyne, C. M., & Coresh, J.
Affiliations
  • National Institute on Aging (US)
  • Johns Hopkins University (US)
  • Novo Nordisk Research Centre Oxford (NNRCO), Oxford OX3 7FZ, UK.
  • Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (US)
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21210, USA.
  • University of Mississippi Medical Center (US)
  • Baylor College of Medicine (US)
  • University of California, San Francisco (US)
  • Broad Institute (US)
  • Department of Mental Health of Older People, Faculty of Brain Sciences, University College London, London WC1E 6BT, UK.
  • Department of Psychiatry, University of Oxford, Oxford OX1 2JD, UK.
  • University of Oxford (GB)
  • National Institute of Neurological Disorders and Stroke (US)
Corresponding author
  • Walker, Keenan A.
  • Coresh, Josef
Venue
Science Translational Medicine
Published
2023-07-19
Volume
15
Issue
705
Pages
eadf5681-eadf5681
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W4384819023
Cited by
148
References
103
Citations by year
2026: 42 · 2025: 56 · 2024: 39 · 2023: 11
FWCI
29.79
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
Funders
  • GlaxoSmithKline
  • Wellcome Trust (221854/Z/20/Z, 350426)
  • European Commission (H2020 SC1, H2020)
  • Rosetrees Trust
  • Deutsche Forschungsgemeinschaft (192904750, CRC992)
  • Albert-Ludwigs-Universität Freiburg
  • Päivikki ja Sakari Sohlbergin Säätiö
  • National Institutes of Health (5u01hl096899-08, 5u01hl096902-08, S011676, Z99 AG999999, H2020)
  • Gillings School of Public Health
  • Horizon 2020 Framework Programme (H2020-SC1)
  • Medical Research Council (S011676, MR/R024227/1, MR/S011676/1, MRC S011676)
  • Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg
  • National Institute on Aging (U01AG058589, RF1AG062553, U01AG052409, R01AG056477, RF1AG059421, ZIAAG000349, ZIAAG000348, P30AG066546)
  • National Heart, Lung, and Blood Institute (HHSN268201700004I, HHSN268201700001I, HHSN268201700005C, HHSN268201700003I, U01HL096814, U01-HL-096899, R01HL087641, R01HL059367, R01HL134320, HHSN268201700005I, U01-HL-096902, HHSN268201700001C, U01HL096917, HHSN268201700002I, HHSN268201700003C, HHSN268201700002C, R01HL070825, HHSN268201700004C, U01HL096812, K24HL155861, R01HL086694)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124399, R01DK100446, R01DK115534, R01DK108803)
  • National Institute of Neurological Disorders and Stroke
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR073178)
  • National Center for Research Resources (UL1RR025005)
  • Janssen Pharmaceuticals
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, dementia risk, plasma proteins, biomarkers, proteomics, middle-aged adults, proteostasis, autophagy, neuroinflammation, cerebrospinal fluid biomarkers, GDF15, alpha-1-antichymotrypsin, coagulation, complement signaling, neurodegeneration, synaptic function, extracellular matrix, neuropsychological outcomes, dementia risk prediction
MeSH terms
Adult, Alzheimer Disease, Brain, Humans, Middle Aged, Biomarkers, Amyloid beta-Peptides, tau Proteins, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life. https://app.cochat.ai/papers/10.1126/scitranslmed.adf5681
The paper
Walker, K. A., Chen, J., Shi, L., Yang, Y., Fornage, M., Zhou, L., Schlosser, P., Surapaneni, A., Grams, M. E., Duggan, M. R., Peng, Z., Gomez, G. T., Tin, A., Hoogeveen, R. C., Sullivan, K. J., Ganz, P., Lindbohm, J. V., Kivimaki, M., Nevado-Holgado, A. J., . . . Coresh, J. (2023). Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adf5681

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.